This Cancellation was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on June 13, 2022 and assigned serial number 92079928 by the TTAB.

Defendant:
Novugen Pharma (Malaysia) Sdn. Bhd. represented by JAMI A. GEKAS of FOLEY & LARDNER LLP.
Trademark Information: NOVUGEN – US Trademark Serial Number 87068080
View Trademark Status at USPTO
View Trademark Documents at USPTO

Plaintiff:
Neuvogen, Inc. represented by JEFFREY A WAKOLBINGER of KATTEN MUCHIN ROSENMAN LLP.
Trademark Information: NEUVOGEN – US Trademark Serial Number 88847538
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
June 13, 2022 – FILED AND FEE
June 14, 2022 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
June 14, 2022 – INSTITUTED
July 21, 2022 – D MOT FOR EXT W/ CONSENT
July 21, 2022 – EXTENSION OF TIME GRANTED
August 22, 2022 – STIP FOR EXT
August 25, 2022 – D MOT TO DISMISS: FRCP 12(B)
September 01, 2022 – P OPP/RESP TO MOTION
September 19, 2022 – D REPLY IN SUPPORT OF MOTION
September 30, 2022 – SUSP PEND DISP OF OUTSTNDNG MOT
September 30, 2022 – D CHANGE OF CORRESP ADDRESS
December 24, 2022 – TRIAL DATES RESET
February 03, 2023 – D APPEARANCE / POWER OF ATTORNEY
February 07, 2023 – RESPONSE DUE
February 07, 2023 – D CHANGE OF CORRESP ADDRESS
February 07, 2023 – D MOT FOR EXT W/ CONSENT
February 08, 2023 – EXTENSION OF TIME GRANTED
March 09, 2023 – ANSWER
April 13, 2023 – P REQ FOR DISCOVERY CONFERENCE-ESTTA
April 20, 2023 – BD ORDER: DISCOVERY CONF HELD
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.